Skip to main content

Advertisement

Log in

Correlation of the expression of telomerase RNA with risk factors for recurrence of sebaceous gland carcinoma

  • Laboratory Investigation
  • Published:
Graefe's Archive for Clinical and Experimental Ophthalmology Aims and scope Submit manuscript

Abstract

Aims

To investigate the expression of human telomerase gene RNA (hTR) and human telomerase reverse transcriptase (hTRT) in eyelid sebaceous gland carcinoma and to evaluate risk factors for sebaceous carcinoma recurrence.

Methods

The expression patterns of hTR and hTRT were detected by in situ hybridization (ISH) in paraffin-embedded samples of 55 eyelid sebaceous gland carcinoma, 12 chalazia, and four sebaceous adenoma. The proliferation index (PI) of sebaceous gland carcinoma was determined by Ki-67 immunolabeling and the results were compared with the expression of hTR and hTRT. Several factors for recurrence of sebaceous gland carcinoma were evaluated by statistical analysis.

Results

Expression of hTR and hTRT was present mainly in the sebaceous gland carcinoma tissues and not in adjacent tissues of carcinoma, chalazia, and sebaceous adenoma. The prevalence of hTR, hTRT, and Ki-67 expression in 55 sebaceous carcinoma samples were 84.45%, 58.1%, and 78.18%, respectively. hTR expression was highly associated with the degree of carcinoma differentiation (P<0.001) and hTRT expression was correlated with the proliferation index as determined by Ki-67 staining (P<0.005). There was a correlation between the recurrence of sebaceous gland carcinoma and the patient's onset age (OR=0.914, P<0.05), as well as the time to first treatment (OR=1.163, P<0.01).

Conclusions

Telomerase may play an important role in the carcinogenesis of sebaceous gland carcinoma, and expression of hTR and hTRT combined with other features of sebaceous gland carcinoma may be helpful for the diagnosis and evaluation of clinical prognosis. Risk factors for recurrence of sebaceous gland carcinoma are patients' onset age and the time to first treatment.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Gerdes J, Lemke H, Baisch H, Wacker HH, Schwab U, Stein H (1984) Cell cycle analysis of a cell proliferation associated human nuclear antigen defined by the monoclonal antibody Ki-67. J Immunol 133:710–715

    Google Scholar 

  2. Greider CW, Blackburn EH (1989) A telomeric sequence in the RNA of Tetrahymena telomerase required for telomere repeat synthesis. Nature 337:331–337

    Article  PubMed  CAS  Google Scholar 

  3. Harle-Bachor C, Boukamp P (1996) Telomerase activity in the regenerative basal layer of the epidermis in human skin and in immortal and carcinoma-derived skin keratinocytes. Proc Natl Acad Sci U S A 93:6476–6481

    Article  PubMed  CAS  Google Scholar 

  4. Hasebe T, Mukai K, Yamaguchi N, Ishihara K, Kaneko A, Takasaki Y, Shimosato Y (1994) Prognostic value of immunohistochemical staining for, proliferating cell nuclear antigen p53 and c-erb-2 in sebaceous gland carcinoma and sweet gland carcinoma: comparison with histopathological parameter. Mod Pathol 7:37–43

    PubMed  CAS  Google Scholar 

  5. Kim NW, Piatyszek MA, Prowse KR, Harley CB, West MD, Ho PL, Coviello GM, Wright WE, Weinrich SL, Shay JW (1994) Specific association of human telomerase activity with immortal cells and cancer. Science 266:2011–2015

    Article  PubMed  CAS  Google Scholar 

  6. Li B, Li N, Sun X, Li L, Chen C (2003) Clinical and histopathologic features in sebaceous gland carcinoma and analysis of prognostic predictors. Recent Adv Ophthalmol 23(2):117–119

    Google Scholar 

  7. Li B, Li N, Sun X, Li L, Chen C (2002) Telomerase expression in sebaceous carcinoma of the eyelid. Chinese J Ophthalmol 38(11):684–687

    Google Scholar 

  8. Li N, Li B, Sun X, Li L, Chen C (2002) Expression of the telomerase RNA correlates with the clinical prognostic analysis of tarsal gland carcinoma. Chinese Ophthalm Resh 20(6):498–501

    CAS  Google Scholar 

  9. Maitra A, Yashima K, Rathi A, Timmons CF, Rogers BB, Shay JW, Gazdar (1999) The RNA component of telomerase as a marker of biologic potential and clinical outcome in childhood neuroblastic tumors. Cancer 85:741–749

    Article  PubMed  CAS  Google Scholar 

  10. Morin GB (1989) The human telomerase terminal transferase enzyme is a riboprotein that synthesizes TTAGGG repeats. Cell 59:521–529

    Article  PubMed  CAS  Google Scholar 

  11. Park TW, Riethdorf S, Riethdorf L, Loning T, Janicke F (1999) Differential telomerase activity, expression of the telomerase catalytic subunit and telomerase-RNA in ovarian tumors. Int J Cancer 84:426–431

    Article  PubMed  CAS  Google Scholar 

  12. Rao NA, Hidayat AA, McLean IW, Zimmerman LE (1982) Sebaceous carcinoma of the ocular adnexa: a clinicopathologic study of 104 cases, with five-year follow-up data. Hum Pathol 13(2):113–122

    Article  PubMed  CAS  Google Scholar 

  13. Rathi A, Hur K, Gazdar AF, Bae JS, Jang JJ, Kim DY (1999) Telomerase RNA expression during progression of gastric cancer. Human Pathol 1302–1307 (Nov 30)

  14. Spencer WH (1985) Ophthalmic pathology, 3rd edn. Saunders, Philadelphia, pp 2201–2214

    Google Scholar 

  15. Wan M, Li WZ, Duggan BD, Felix JC, Zhao Y, Dubeau L (1997) Telomerase activity in benign and malignant epithelial ovarian tumors. J Natl Cancer Inst 89:437–441

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Bin Li.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Li, B., Li, N., Cheng, G. et al. Correlation of the expression of telomerase RNA with risk factors for recurrence of sebaceous gland carcinoma. Graefe's Arch Clin Exp Ophthalmo 244, 480–484 (2006). https://doi.org/10.1007/s00417-005-0089-1

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00417-005-0089-1

Keywords

Navigation